Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x100px

Document › Details

BioNTech SE. (8/7/23). "Press Release: BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update". Mainz.

	Organisation	BioNTech SE (Nasdaq: BNTX)
	Group	BioNTech (Group)
	Organisation 2	Duality Biologics (Suzhou) Co. Ltd. (DualityBio)
	Product	antibody-drug conjugate (ADC)
	Product 2	drug development
	Index term 2	BioNTech–Duality Biologics: antibody-drug conjugates, 202304– license excl ww excl China for DB-1303 + DB-1311 $170m upfront + >$1.5b milestones + roy
	Person	Sahin, Ugur (BioNTech 201207 Managing Director BioNTech + Ribological GmbH)
	Person 2	Alatovic, Jasmina (BioNTech 202005 Senior Manager Global External Communications)

Original document
accessed by [iito] on 2023-08-07

Record changed: 2024-03-14

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for BioNTech (Group)

[1] BioNTech SE. (11/13/24). "Press Release: BioNTech to Acquire Biotheus to Boost Oncology Strategy". Mainz....
[2] Tempus AI, Inc.. (9/4/24). "Press Release: Tempus Announces Real World Data Collaboration with BioNTech". Chicago....
[3] BioNTech SE. (8/22/24). "Press Release: Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine". New York, NY & Mainz....
[4] BioNTech SE. (8/19/24). "Press Release: Lift of Partial Clinical Hold for BNT326/YL202"....
[5] BioNTech SE. (8/16/24). "Press Release: Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age". New York, NY & Mainz....
[6] BioNTech SE. (8/5/24). "Press Release: BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update". Mainz....
[7] Triastek, Inc.. (7/23/24). "Press Release: Triastek Announces Research Collaboration and Platform Technology License Agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics". Nanjing....
[8] Haya Therapeutics SA. (7/1/24). "Press Release: Haya Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award". Lausanne & San Diego, CA....
[9] BioNTech SE. (6/24/24). "Press Release: BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer". Mainz & Shanghai....
[10] BioNTech SE. (5/29/24). "Press Release: BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem". Mainz & Oslo....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]